U.S. Semiconductors Stock News

In March 2026, H.B. Fuller reported first-quarter 2026 results showing sales of US$770.84 million versus US$788.66 million a year earlier, with net income rising to US$21.05 million and basic and diluted EPS from continuing operations increasing to US$0.38 from US$0.24. Alongside this profitability improvement, the company raised its full-year 2026 net revenue guidance to mid-single-digit growth and signaled low-single-digit growth for the second quarter, indicating management’s increased...

If you are wondering whether PDD Holdings at around US$98.42 offers good value or just extra risk, you will want to see how the current price stacks up against its fundamentals. The stock has recently shown a 2.3% gain over the last 7 days, while returns stand at a 5.1% decline over 30 days, a 15.0% decline year to date, and a 16.8% decline over the past year, set against a 31.5% return over three years and a 31.1% decline over five years. Recent coverage has focused on PDD Holdings as a...

Ameris Bancorp (ABCB) has drawn fresh attention after a recent move in its share price, with the stock closing at US$76.53. Investors are weighing this level against its recent performance and fundamentals. See our latest analysis for Ameris Bancorp. The recent 0.84% 1-day share price return, putting Ameris Bancorp at US$76.53, sits against a modest 3.45% year-to-date share price return but a much stronger 34.41% 1-year total shareholder return, suggesting momentum has been building over a...

If you are wondering whether Automatic Data Processing (ADP) now offers fair value or a possible mispricing, the recent share performance provides several points to consider. The stock last closed at US$205.42, with a 2.0% decline over 7 days, a 4.2% decline over 30 days, an 18.8% decline year to date, but still 1.5% and 18.4% gains over 3 and 5 years respectively. Recent attention around ADP has focused on how its share price pullback compares with its long-run record and ongoing role as a...

Earlier this month, WD-40 Company declared a quarterly dividend of US$1.02 per share, payable on April 30, 2026, and also participated in the 38th Annual Roth Conference with its senior leadership team presenting to investors. Alongside this dividend decision, management highlighted the resilience of its maintenance-product franchise, with growth led by higher-margin WD-40 Specialist offerings and expanding e-commerce channels that management believes could support a US$1.40 billion market...

Index removal puts fresh focus on Ziff Davis Ziff Davis (ZD) has been removed from the NASDAQ Internet Index, an adjustment that can prompt portfolio shifts for index-tracking funds and encourage investors to reassess how the stock fits within internet sector exposures. See our latest analysis for Ziff Davis. The latest index exit comes after a sharp 54.8% 30 day share price return, alongside a 23.3% year to date share price gain. The 1 year total shareholder return of 11.6% contrasts with a...

Regulatory and consumer groups in Ohio are challenging American Electric Power Company's cost recovery approach for a $1.1b Grid Growth Ohio transmission project. The dispute centers on the proposed return on equity and formula rate, which opponents argue may shift data center related costs onto Ohio ratepayers without sufficient safeguards. The case is now before the Federal Energy Regulatory Commission, putting the project structure and cost allocation under closer regulatory review. For...

Todd Combs, a long-time Berkshire Hathaway investment manager and former GEICO CEO, left the conglomerate at the end of last year to run money for Jamie Dimon at JPMorgan Chase, marking a meaningful leadership shift for both firms. His departure comes as Berkshire Hathaway faces questions about its recent performance and portfolio stewardship, sharpening investor focus on succession and capital allocation decisions. We will now examine how Todd Combs’ exit and the recent performance...

Earlier in 2026, Better Home & Finance and Coinbase launched a Fannie Mae-approved mortgage product that lets borrowers pledge Bitcoin or USDC as collateral for conforming home loans without selling their crypto holdings. This first-ever integration of digital assets into the Fannie Mae framework could widen access to homeownership for crypto-focused, typically younger borrowers while testing how traditional housing finance handles crypto-related risks. We’ll now examine how Fannie Mae’s...

Sigma Lithium (NasdaqCM:SGML) just posted its FY 2025 third quarter scorecard with revenue of US$28.5 million and a basic EPS loss of US$0.10, alongside net income excluding extra items of a US$11.6 million loss. The company has seen quarterly revenue move between US$16.9 million and US$47.7 million over the past three reported quarters, with basic EPS ranging from a profit of US$0.04 to losses of US$0.17. Trailing twelve month EPS stands at a loss of US$0.30 on revenue of US$139.0 million...

IonQ (NYSE:IONQ) has entered a definitive agreement to acquire SkyWater Technology in a deal valued at US$1.8b. The transaction deepens IonQ’s control over its quantum hardware supply chain by bringing a semiconductor and foundry partner in house. This move is positioned to support IonQ’s efforts toward commercially viable, fault tolerant quantum computing. For readers tracking quantum computing, IonQ is one of the better known pure play names, focused on building trapped ion quantum...

If you are wondering whether nLIGHT's share price still reflects its underlying value, it helps to step back from the excitement and look closely at what the numbers actually say. The stock trades at US$53.98 after a 40.7% return year to date, which comes on top of a very large 1 year gain and a 438.7% return over 3 years, despite a recent 22.8% 7 day pullback and a modest 3.9% 30 day decline. Recent coverage has focused on nLIGHT's position in high performance laser technology and its role...

Earlier in March 2026, Casella Waste Systems, Inc. appointed Christopher A. Rains as Senior Vice President and Chief Revenue Officer, adding a leader with more than two decades of commercial, operational, and customer-focused experience across major waste management and industrial companies. Rains’ combination of industry depth, Lean Six Sigma Black Belt training, and proven work on complex organizational transformations introduces fresh commercial leadership that could influence how Casella...

Papa John’s International recently launched Oven-Toasted Sandwiches on toasted ciabatta-style bread, featuring high-quality meats, white American cheese, new signature sauces, and bundle pricing starting at US$7.99. This move extends Papa John’s beyond its traditional pizza focus, using premium, garlic-sauce-brushed sandwiches to try to refresh demand amid weak same-store sales and higher operating costs. Next, we’ll consider how this push into indulgent, garlic-brushed Oven-Toasted...

Apogee Therapeutics recently reported positive 52-week Phase 2 APEX trial data for its lead anti-IL-13 antibody zumilokibart in moderate-to-severe atopic dermatitis, alongside completing a follow-on common stock offering of about US$403,000,000 at US$70 per share. The maintenance data suggest zumilokibart may offer durable disease control with 3- or 6-month dosing intervals, a dosing schedule that could meaningfully differentiate it from existing atopic dermatitis treatments if later-stage...

Middleby stock performance and recent context Middleby (MIDD) has been under pressure recently, with the share price showing negative returns over the past week, month and past 3 months, prompting investors to reassess how its current valuation lines up with the underlying business. See our latest analysis for Middleby. The recent 24.68% 30 day share price decline, alongside a 16.31% 1 year total shareholder return decline, suggests momentum has faded and investors are reassessing Middleby at...

In March 2026, Protagonist Therapeutics reported one-year Phase 3 data for ICOTYDE (icotrokinra) in moderate to severe plaque psoriasis, showing sustained skin clearance and a favorable safety profile as the first oral IL-23 receptor–targeted peptide. The data, including adolescent results through Week 52, underline ICOTYDE’s potential as a once-daily pill alternative to injectable treatments and highlight the company’s peptide discovery platform. We’ll now look at how ICOTYDE’s...

Event context and recent price performance Biglari Holdings (BH.A) recently caught investor attention after a 3% move in the latest session, contrasting with a decline of about 17% over the past month and a smaller pullback over the past 3 months. See our latest analysis for Biglari Holdings. That recent 3% daily share price move sits against a weaker short term trend, with a 30 day share price return of about a 17% decline. However, the 1 year total shareholder return of 50.73% and 5 year...

Mother’s Day collaboration puts Bath & Body Works stock in focus Bath & Body Works (BBWI) is drawing fresh investor attention after unveiling a Vera Bradley collaboration for Mother’s Day, a limited-edition collection that spans body care, home fragrance, decor and accessories. See our latest analysis for Bath & Body Works. That Mother’s Day launch lands at a time when the 1-day share price return of 11.13% stands in contrast to a 30-day share price return decline of 17.97% and a 1-year total...

In the first quarter ended February 28, 2026, KB Home reported lower sales and net income year over year, while also completing a US$150 million share repurchase totaling 2,397,196 shares under its October 2025 authorization. At the same time, management issued revenue guidance for the second quarter and full year 2026 that frames housing revenues within a relatively tight range, underscoring a cautious demand outlook despite continued capital returns. Next, we will examine how KB Home’s...

At the March 12, 2026 BofA Securities Information & Business Services Conference, First Advantage Corporation highlighted 17% fourth-quarter revenue growth, a transition toward capital risk management solutions, and board approval of a US$100,000,000 share repurchase program. The company’s emphasis on expanding beyond background screening into a broader capital risk management platform, supported by about 97% client retention, underlines management’s confidence in scaling the business...

Relay Therapeutics (RLAY) is back in focus after releasing new Phase 1/2 ReDiscover trial data for zovegalisib plus fulvestrant in PI3Ka-mutated, HR+/HER2- metastatic breast cancer, supporting its selected Phase 3 dosing regimen. See our latest analysis for Relay Therapeutics. The latest trial update comes after a sharp move in the stock, with a 1 day share price return of negative 5.14% and a 30 day share price return of negative 6.43%. However, a 1 year total shareholder return of 266.41%...

Recently, Globant and PharmaMar announced a collaboration to apply Globant Enterprise AI in accelerating cancer drug discovery, while Globant and Adyen formalized a global partnership making Globant a lead integration partner for Adyen’s payments platform. Together, these alliances show how Globant is embedding its AI and integration capabilities at the core of critical workflows in both healthcare R&D and global payments infrastructure. Now we’ll examine how Globant’s AI-powered PharmaMar...

With no single headline event driving Allegion (ALLE) into focus, investors are instead looking at the stock's recent performance and fundamentals, including its US$4,067.3m in revenue and US$643.8m in net income. See our latest analysis for Allegion. Allegion’s recent share price performance has been soft, with a 1-month share price return of 10.33% and a year to date share price return of 10.2%. The 1-year total shareholder return sits at 12.27%, which hints at longer term holders faring...